MarketFriction

Socrus Bio Sciences Ltd

BSE 524719
Market cap₹Cr.
Not trading

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Mar 2013Jun 2013Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014
Sales3.553.750.100.050.250.430.250.24
Expenses20.233.480.110.070.370.440.240.23
Operating Profit-16.680.27-0.01-0.02-0.12-0.010.010.01
OPM %-469.86%7.20%-10.00%-40.00%-48.00%-2.33%4.00%4.17%
Other Income-1.510.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Depreciation0.020.000.000.000.000.000.000.00
Profit before tax-18.210.27-0.01-0.02-0.12-0.010.010.01
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit-18.210.27-0.01-0.02-0.12-0.010.010.01
EPS in Rs-5.690.08-0.00-0.01-0.04-0.000.000.00
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013TTM
Sales11.669.515.325.705.4022.0830.1619.891.17
Expenses14.439.595.655.835.4124.0123.7039.831.28
Operating Profit-2.77-0.08-0.33-0.13-0.01-1.936.46-19.94-0.11
OPM %-23.76%-0.84%-6.20%-2.28%-0.19%-8.74%21.42%-100.25%-9.40%
Other Income0.81-0.680.820.360.076.230.04-15.100.00
Interest0.290.550.410.090.000.000.000.000.00
Depreciation0.060.070.070.060.070.060.054.320.00
Profit before tax-2.31-1.380.010.08-0.014.246.45-39.36-0.11
Tax %-25.97%-23.19%-2,200.00%75.00%-1,500.00%-8.96%20.62%0.00%
Net Profit-1.71-1.060.230.020.144.625.12-39.36-0.11
EPS in Rs1.441.60-12.30-0.04
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%30%54%-84%
Compounded Profit Growth%%%99%
Stock Price CAGR%%%%
Return on Equity%-19%-25%-116%
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013
Equity Capital14.6514.6514.6514.6514.6532.0032.0032.00
Reserves-1.97-3.03-2.80-2.78-2.633.518.63-30.73
Borrowings65.3466.1670.080.000.000.000.000.00
Other Liabilities2.020.430.030.030.020.040.070.97
Total Liabilities80.0478.2181.9611.9012.0435.5540.702.24
Fixed Assets0.910.840.780.710.6422.7222.680.00
CWIP0.000.000.000.000.000.000.000.00
Investments2.280.760.000.000.000.000.000.00
Other Assets76.8576.6181.1811.1911.4012.8318.022.24
Total Assets80.0478.2181.9611.9012.0435.5540.702.24
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013
Cash from Operating Activity-51.39-2.20-4.9369.980.073.30-0.06-3.30
Cash from Investing Activity0.001.520.780.000.00-22.180.003.26
Cash from Financing Activity51.310.823.92-70.070.0018.910.000.00
Net Cash Flow-0.080.14-0.23-0.090.070.03-0.06-0.04
Free Cash Flow-51.39-2.20-4.9369.980.07-14.53-0.06-0.04
CFO/OP1,855%2,750%1,494%-53,831%-700%-171%-1%17%
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013
Debtor Days41.3221.4937.7346.11117.6188.2782.540.00
Inventory Days168.52254.72413.45400.34265.3343.3994.089.98
Days Payable47.377.770.660.641.370.820.9310.53
Cash Conversion Cycle162.47268.45450.52445.81381.57130.84175.69-0.55
Working Capital Days2,306.452,862.055,457.85621.14655.65153.08191.585.14
ROCE %0.63%0.56%0.36%-0.08%-7.78%16.94%-115.80%

Fundamentals

Market Cap₹ Cr.
Current Price₹ 0.48
Book Value₹ 0.40
ROCE-116 %
ROE-116 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-84%
Compounded Profit Growth (TTM)99%
Standalone figures.
Valuation
P/E, 3-year average62.15x
P/B, 3-year average0.35x
P/E, 5-year average54.58x
P/B, 5-year average0.38x
Profitability
Operating margin (excl. other income)-8.74%
Operating margin (incl. other income)19.47%
EBITDA margin-12.05%
Pre-tax margin-19.28%
Net profit margin-19.28%
Net margin, latest quarter-2.33%
ROE19.44%
ROCE17.84%
ROA19.42%
ROE, 3-year average6.93%
ROCE, 3-year average6.04%
ROA, 3-year average6.88%
ROE, 5-year average2.80%
ROCE, 5-year average3.52%
ROA, 5-year average3.92%
ROIC (approx.)-0.49%
Tax rate-8.96%
Other income / net worth17.54%
Growth
Sales growth (latest year)308.89%
Profit growth (latest year)3200.00%
Sales CAGR, 3 years60.70%
Sales CAGR, 5 years13.62%
Profit CAGR, 3 years171.83%
Sales growth QoQ72.00%
Sales growth YoY (latest quarter)-88.53%
Profit growth YoY (latest quarter)-103.70%
Per share
EPS (TTM)Rs -0.05
EPS (latest year)Rs 1.44
EPS (latest quarter)Rs -0.00
EPS, 3-year averageRs 0.52
EPS, 5-year averageRs 0.20
Book value per shareRs 11.10
Sales per shareRs 0.26
Cash flow per shareRs 1.03
Free cash flow per shareRs -0.01
Efficiency
Asset turnover0.62x
Fixed asset turnover0.97x
Inventory turnover8.41x
Inventory days43 days
Debtor days88 days
Debtors turnover4.13x
Creditor days11 days
Cash conversion cycle-1 days
Working capital days5 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Owners' fund to total sources99.89%
Cash flow
Cash from Operating Activity (latest year)Rs 3 Cr
Cash from Investing Activity (latest year)Rs -22 Cr
Cash from Financing Activity (latest year)Rs 19 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -0 Cr
Sales to cash flow6.69x
Statement figures
Net sales (TTM)Rs 1 Cr
Net sales (latest year)Rs 22 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit excl. other income (latest year)Rs -2 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 6 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -0 Cr
Tax (latest year)Rs -0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest year)Rs 5 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 18 Cr
Total expenditure (latest year)Rs 24 Cr
Total income (latest year)Rs 28 Cr
Share capitalRs 32 Cr
ReservesRs 4 Cr
Shareholders' fundsRs 36 Cr
Total assetsRs 36 Cr
Net blockRs 23 Cr
ReceivablesRs 5 Cr
InventoryRs 2 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)3.20
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.

Red flags

F-score 6 of 8
lookProfit leans on other income Other income was 147% of pre-tax profit in 2013
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Dec 2014
Sales ₹0 Cr +380.0% vs Dec 2013. Net profit ₹0 Cr +150.0%.

Activity

Compare
No listed peers in this industry.
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Socrus Bio Sciences Ltd?

Socrus Bio Sciences Ltd (524719) has a market capitalisation of Rs Cr. at the close.

What were Socrus Bio Sciences Ltd's latest quarterly results?

In the Dec 2014 quarter, Socrus Bio Sciences Ltd sales was Rs 0 Cr (+380.0% vs Dec 2013) and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03